Diclofenac, sold under the brand name Voltaren among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammatory diseases such as gout.[4][9] It can be taken orally (swallowed by mouth), inserted rectally as a suppository, injected intramuscularly, injected intravenously, applied to the skin topically, or through eye drops.[9][10][11] Improvements in pain last up to eight hours.[9] It is also available as the fixed-dose combination diclofenac/misoprostol (Arthrotec) to help protect the stomach; however, proton pump inhibitors such as omeprazole are typically first-line since they are at least as effective as misoprostol, but with better tolerability.[12][13]
Common side effects include abdominal pain, gastrointestinal bleeding, nausea, dizziness, headache, and swelling.[9] Serious side effects may include heart disease, stroke, kidney problems, and stomach ulceration.[9] Use is not recommended in the third trimester of pregnancy.[9] It is likely safe during breastfeeding. Diclofenac is believed to work by decreasing the production of prostaglandins, like other drugs in this class.[14]
In 2023, it was the 73rd most commonly prescribed medication in the United States, with more than 9million prescriptions.[15][16] It is available as its acid or in two salts, as either diclofenac sodium or potassium.[17]
Medical uses
Diclofenac is used to treat pain related to arthritis, dysmenorrhea, rheumatic diseases and other inflammatory disorders,[9] kidney stones and gallstones. An additional indication is the treatment of acute migraines.[5] Diclofenac is used to treat mild to moderate postoperative or post-traumatic pain, in particular when inflammation is also present.
Diclofenac ophthalmic is indicated for the treatment of postoperative inflammation in people who have undergone cataract extraction and for the temporary relief of pain and photophobia in people undergoing corneal refractive surgery.[18]
Diclofenac is also available in topical forms and is useful for osteoarthritis but not other types of long-term musculoskeletal pain.[19] Diclofenac may also help with actinic keratosis and with acute pain caused by minor strains, sprains and contusions.[20]
In many countries, eye drops are sold to treat acute and chronic nonbacterial inflammation of the anterior part of the eyes (such as postoperative states).[21] The eye drops have also been used to manage pain for traumatic corneal abrasion.[22]
Diclofenac is often used to treat chronic pain associated with cancer, especially if inflammation is present.[23]
Contraindications
Diclofenac is contraindicated for pregnant women; for people with active stomach or duodenal ulceration or gastrointestinal bleeding; and for people undergoing coronary artery bypass surgery.[9][24][25]
Adverse effects
Diclofenac consumption has been associated with significantly increased vascular and coronary risk in a study including COX-2 inhibitors, diclofenac, ibuprofen and naproxen.[26] Upper gastrointestinal complications were also reported.[26] Major adverse cardiovascular events were increased by about a third by diclofenac, chiefly due to an increase in major coronary events.[26] Compared with placebo, of 1000 patients allocated to diclofenac for a year, three more had major vascular events, one of which was fatal.[26] Vascular death is increased significantly by diclofenac.[26]
In October 2020, the US Food and Drug Administration (FDA) required the prescribing information to be updated for all nonsteroidal anti-inflammatory medications to describe the risk of kidney problems in fetuses that result in low amniotic fluid.[27][28]
Heart
In 2013, a study found major vascular events were increased by about a third by diclofenac, chiefly due to an increase in major coronary events.[26] Compared with placebo, of 1000 people allocated to diclofenac for a year, three more had major vascular events, one of which was fatal.[26] Vascular death was increased by diclofenac (1·65).[26]
Following the identification of increased risks of heart attacks with the selective COX-2 inhibitor rofecoxib in 2004, attention has focused on all the other members of the nonsteroidal anti-inflammatory drug group, including diclofenac. Research results are mixed, with a meta-analysis of papers and reports up to April 2006 suggesting a relative increased rate of heart disease of 1.63 compared to nonusers.[29] Professor Peter Weissberg, medical director of the British Heart Foundation said, "However, the increased risk is small, and many patients with chronic debilitating pain may well feel that this small risk is worth taking to relieve their symptoms". Only aspirin was found not to increase the risk of heart disease; however, this is known to have a higher rate of gastric ulceration than diclofenac. As of January 2015, the MHRA announced that diclofenac would be reclassified as a prescription-only medicine (POM) due to the risk of cardiovascular adverse events.[30]
A 2006 large observational study of 74,838 US users of nonsteroidal anti-inflammatory drugs or coxibs found no additional cardiovascular risk from diclofenac use.[31] A very large study of 1,028,437 Danish users of various nonsteroidal anti-inflammatory drugs or coxibs found the "Use of the nonselective NSAID diclofenac and the selective cyclooxygenase-2 inhibitor rofecoxib was associated with an increased risk of cardiovascular death (odds ratio, 1.91; 95% confidence interval, 1.62 to 2.42; and odds ratio, 1.66; 95% confidence interval, 1.06 to 2.59, respectively), with a dose-dependent increase in risk."[32]
Diclofenac is similar in COX-2 selectivity to celecoxib.[33]
Gastrointestinal
- Gastrointestinal complaints are most often noted. Most patients receive a gastro-protective drug as prophylaxis during long-term treatment (misoprostol, ranitidine, or omeprazole).
Liver
- Liver damage occurs infrequently, and is usually reversible. Hepatitis may occur rarely without any warning symptoms and may be fatal. Patients with osteoarthritis more often develop symptomatic liver disease than patients with rheumatoid arthritis. If used for the short-term treatment of pain or fever, diclofenac has not been found more hepatotoxic than other nonsteroidal anti-inflammatory drugs.[34]
- As of, Endo, Novartis, and the US FDA notified healthcare professionals to add new warnings and precautions about the potential for elevation in liver function tests during treatment with all products containing diclofenac sodium.[35]
- Cases of drug-induced hepatotoxicity have been reported in the first month but can occur at any time during treatment with diclofenac. Postmarketing surveillance has reported cases of severe hepatic reactions, including liver necrosis, jaundice, fulminant hepatitis with and without jaundice, and liver failure. Some of these reported cases resulted in fatalities or liver transplantation.[36]
Kidney
- Nonsteroidal anti-inflammatory drugs "are associated with adverse renal [kidney] effects caused by the reduction in synthesis of renal prostaglandins"[37] in sensitive persons or animal species, and potentially during long-term use in nonsensitive persons if resistance to side effects decreases with age. However, this side effect cannot be avoided merely by using a COX-2 selective inhibitor because, "Both isoforms of COX, COX-1, and COX-2, are expressed in the kidney...
Mental health
- Mental health side effects have been reported. These symptoms are rare but exist in significant enough numbers to include as potential side effects. These include depression, anxiety, irritability, nightmares, and psychotic reactions.[38]
Pharmacology
As with other nonsteroidal anti-inflammatory drugs, the primary mechanism responsible for its anti-inflammatory, antipyretic and analgesic action is thought to be inhibition of prostaglandin synthesis through COX-inhibition.
The main target in the inhibition of prostaglandin synthesis appears to be the transiently expressed prostaglandin-endoperoxide synthase-2 (PGES-2), also known as cycloxygenase-2 (COX-2). That is, diclofenac is partially selective for COX-2. The reported selectivity for COX-2 varies from 1.5 to 30 depending on the source.[39][40][41][42]
The drug may be bacteriostatic via inhibiting bacterial DNA synthesis.[43]
Diclofenac has a relatively high lipid solubility, making it one of the few nonsteroidal anti-inflammatory drugs that are able to enter the brain by crossing the blood-brain barrier.[44] As in the rest of the body, it is thought to exert its effect in the brain through inhibition of COX-2.[44] In addition, it may have effects inside the spinal cord.[45]
Diclofenac may be a unique member of the nonsteroidal anti-inflammatory drugs in other aspects. Some evidence indicates it inhibits the lipoxygenase pathways,[46][47] thus reducing the formation of leukotrienes (also pro-inflammatory autacoids). It also may inhibit phospholipase A2, which may be relevant to its mechanism of action. These additional actions may explain its high potency –it is the most potent NSAID on a broad basis.[48]
Marked differences exist among nonsteroidal anti-inflammatory drugs in their selective inhibition of the two subtypes of cyclooxygenase, COX-1, and COX-2.[49] Drug developers have focused on selective COX-2 inhibition, particularly as a way to minimize the gastrointestinal side effects of nonsteroidal anti-inflammatory drugs. However, the cardiovascular adverse effects of some COX-2 inhibitors has led to lawsuits alleging wrongful death by heart attack. Yet, other significantly COX-selective nonsteroidal anti-inflammatory drugs, such as diclofenac, have been well tolerated by most of the population.
Besides the COX-inhibition, several other molecular targets of diclofenac possibly contributing to its pain-relieving actions have recently been identified. These include:
The duration of action (i.e., duration of pain relief) of a single dose is longer (6 to 8 h) than the drug's 1.2–2 h half-life. This may be partly due to its persistence for over 11 hours in synovial fluids.[54]
- Blockage of voltage-dependent sodium channels (after activation of the channel, diclofenac inhibits its reactivation, also known as phase inhibition)[50][51]
- Blockage of acid-sensing ion channels (ASICs)[52]
- Positive allosteric modulation of KCNQ- and BK-potassium channels (diclofenac opens these channels, leading to hyperpolarization of the cell membrane)[53][51]
History
Diclofenac was first synthesized by Alfred Sallmann and Rudolf Pfister in 1973.[55][56] The name "diclofenac" derives from its chemical name: 2-(2,6-dichloranilino) phenylacetic acid. It was patented in Germany in 1978 by Ciba-Geigy (now Novartis).[57][58] It came into medical use in the United States in 1988.[9] GlaxoSmithKline purchased the rights in 2015.[55] It is available as a generic medication.[9]
Formulations and brand names
Diclofenac formulations are available worldwide under many different brand names.[59]
Voltaren and Voltarol contain the sodium salt of diclofenac. In the United Kingdom, Voltarol can be supplied with either the sodium salt or the potassium salt, while Cataflam, sold in some other countries, is the potassium salt only. However, Voltarol Emulgel contains diclofenac diethylammonium 1.16%, being equivalent to 1% sodium salt. In 2016, Voltarol was one of the biggest selling branded over-the-counter medications sold in Great Britain, with sales of £39.3 million.[60]
In the United States, 1% diclofenac gel was approved by the FDA in 2007 as a prescription drug for the temporary relief of the pain of osteoarthritis of joints in the hands, knees, and feet. In 2020, the FDA approved the gel formulation for nonprescription use.[6]
In January 2015, diclofenac oral preparations were reclassified as prescription-only medicines in the UK. The topical preparations are available without a prescription.[61]
Ecological effects
Diclofenac in animals has environmental effects. It is toxic, for example, to scavenging birds.[62] Too, residues of the drug are found in marine and freshwater organisms, contaminated by agricultural runoff containing diclofenac. The medication has been banned for veterinary use in several countries; India restricted its use in 2006.[63][64] Meloxicam is an alternative which is safer for wildlife.[65][66]
Veterinary use in livestock resulted in a sharp decline in the vulture population in the Indian subcontinent – a 95% decline by 2003[67] and a 99.9% decline by 2008. Vultures are long-lived and slow to breed. They start breeding only at the age of six and only 50% of their young survive. Even if the Indian government ban is fully implemented, it will take many years to revive the vulture population.[68]
The mechanism of toxicity in vultures is presumed to be kidney failure;[69] however, toxicity may be due to direct inhibition of uric acid secretion in vultures.[70] Vultures eat the carcasses of livestock that have been administered veterinary diclofenac, and are poisoned by the accumulated chemical,[71] as vultures do not have a particular enzyme to break down diclofenac. At a meeting of the National Wildlife Board in March 2005, the Government of India announced it intended to phase out the veterinary use of diclofenac.[72]
Steppe eagles have the same vulnerability to diclofenac as Old World vultures and are therefore at similar risk from its effects.[73] In contrast, New World vultures, such as the turkey vulture, can tolerate at least 100 times the level of diclofenac that is lethal to Gyps species.[74]
Despite the vulture crisis, diclofenac remains available in other countries including many in Europe.[75] It was controversially approved for veterinary use in Spain in 2013 and continues to be available, despite Spain being home to around 90% of the European vulture population and an independent simulation showing that the drug could reduce the population of vultures by 1–8% annually. Spain's medicines agency presented simulations suggesting that the number of deaths would be quite small.[76] A paper published in 2021 identified the first authenticated death of a vulture from diclofenac in Spain, a cinereous vulture.[62][77]
Diclofenac is on the European Union's watch list because it pollutes the Baltic Sea. When the substance enters fresh water, it has an environmental impact and is considered more difficult to remove in wastewater treatment plants than, for example, ibuprofen.[78] Diclofenac has been shown also to harm freshwater fish species such as rainbow trout.[79][80][81][82] Harmful residues have been found in fish, blue mussels, and other aquatic organisms, where it has been found to cause damage to internal organs such as the gills, kidneys and liver.[83]
Veterinary use
Diclofenac is used for livestock; such use was responsible for the Indian vulture crisis, during which in a few years 95% of the country's vulture population was killed. In many countries, agricultural use is now forbidden.[84][62][85][86]
Diclofenac is approved as a veterinary medication in some countries[84][62][85][86] for the treatment of pets as well as in livestock. In some species of birds, diclofenac causes accumulation of uric acid crystals in internal organs—especially the liver and kidneys—resulting in visceral gout, as well as cellular damage and necrosis.[87] In South Asia in the 2000s, vulture populations were decimated after feeding on carcasses of livestock that had been treated with diclofenac.[88]
External links
References
- Mosby's Dictionary of Medicine, Nursing & Health Professions Elsevier, 2017^
- Diclofenac Use During Pregnancy Drugs.com, 16 January 2000, retrieved 18 February 2024^
- Product monograph brand safety updates Health Canada, 6 June 2024, retrieved 8 June 2024^
- Voltaren Arthritis Pain- diclofenac sodium gel; Voltaren Arthritis Pain- diclofenac sodium kit DailyMed, 13 March 2024, retrieved 13 October 2024^
- Cambia- diclofenac potassium powder, for solution DailyMed, 25 April 2024, retrieved 13 October 2024^
- FDA Approves Three Drugs for Nonprescription Use Through Rx-to-OTC Switch Process U.S. Food and Drug Administration (FDA), 14 February 2020, retrieved 18 February 2024^
- Diclofenac Oral Uses, Dosage, Side Effects And Composition Medicine Reviews Agency, 23 August 2018, retrieved 18 February 2024^
- Essentials of Pain Medicine W.B. Saunders, 1 January 2011, retrieved 10 January 2023^
- Diclofenac epolamine Monograph for Professionals Drugs.com, retrieved 18 February 2024^
- The use of Injectable Nonsteroidal Anti-Inflammatory Drugs in Local Accident & Emergency Practice Hong Kong Journal of Emergency Medicine, 2017^
- Diclofenac Ophthalmic medlineplus.gov, 2016-07-15, retrieved 2024-10-08^
- Arthrotec- diclofenac sodium and misoprostol tablet, film coated DailyMed, 16 August 2023, retrieved 13 October 2024^
- Non-steroidal anti-inflammatory drugs and the gastrointestinal tract Clinical Medicine, March 2021^
- Mosby's Drug Reference for Health Professions Elsevier Health Sciences, 2017^
- Top 300 of 2023 ClinCalc, retrieved 12 August 2025^
- Diclofenac Drug Usage Statistics, United States, 2013 - 2023 ClinCalc, retrieved 18 August 2025^
- British national formulary: BNF 74 British Medical Association, 2017^
- Voltaren- diclofenac sodium solution DailyMed, 1 October 2012, retrieved 13 October 2024^
- Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice International Journal of Antimicrobial Agents, 2007^
- Diclofenac (Topical Application Route) Description and Brand Names MayoClinic.com, Mayo Clinic^
- Naclof, oogdruppels 1 mg/ml Laboratoires THEA, Netherlands Medicines Authority MEB^
- Topical non-steroidal anti-inflammatory drugs for analgesia in traumatic corneal abrasions The Cochrane Database of Systematic Reviews, May 2017^
- WHO's cancer pain ladder for adults World Health Organization (WHO), 27 November 2013, retrieved 26 April 2020^
- Diclofenac Sodium Topical Solution: PI Drugs.com, 5 August 2024, retrieved 13 October 2024^
- Diclofenac Sodium- diclofenac gel DailyMed, 30 March 2018, retrieved 13 October 2024^
- Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials Lancet, August 2013^
- FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications U.S. Food and Drug Administration (FDA), 15 October 2020, retrieved 15 October 2020^
- NSAIDs may cause rare kidney problems in unborn babies U.S. Food and Drug Administration (FDA), 21 July 2017, retrieved 15 October 2020^
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials BMJ, June 2006^
- Press release: Diclofenac tablets now only available as a prescription medicine Medicines and Healthcare products Regulatory Agency, 14 January 2015, retrieved 14 January 2015^
- Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk Arthritis and Rheumatism, May 2006^
- Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals Circulation: Cardiovascular Quality and Outcomes, July 2010^
- The coxibs, selective inhibitors of cyclooxygenase-2 The New England Journal of Medicine, August 2001^
- Diclofenac LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, National Institute of Diabetes and Digestive and Kidney Diseases, 2012, retrieved 2025-12-22^
- Voltaren Gel (diclofenac sodium topical gel) 1% – Hepatic Effects Labeling Changes U.S. Food and Drug Administration (FDA), 4 December 2009^
- Fernando Bessone. Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? World Journal of Gastroenterology, 2010^
- Renal effects of cyclooxygyenase-2-selective inhibitors Journal of Pain and Symptom Management, April 2002^
- Diclofenac Side Effects Drugs.com, retrieved 21 January 2013^
- Diclofenac National Library of Medicine, 15 January 2024, retrieved 15 January 2024^
- Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs The Journal of Clinical Investigation, July 2001^
- Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis Proceedings of the National Academy of Sciences of the United States of America, June 1999^
- Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase Proceedings of the National Academy of Sciences of the United States of America, December 1993^
- The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis International Journal of Antimicrobial Agents, April 2000^
- Diclofenac: update on tolerableness and spinal anti-inflammatory action Minerva Medica, August 2014, retrieved 23 April 2023^
- Spinal antinflammatory action of Diclofenac Minerva Medica, June 2016, retrieved 23 April 2023^
- Diclofenac: an update on its mechanism of action and safety profile Current Medical Research and Opinion, July 2010^
- Effect of diclofenac sodium on the arachidonic acid cascade The American Journal of Medicine, April 1986^
- Pharmacology of diclofenac sodium The American Journal of Medicine, April 1986^
- Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs The American Journal of Medicine, May 1998^
- The non-steroidal anti-inflammatory drug, diclofenac, inhibits Na(+) current in rat myoblasts Biochemical and Biophysical Research Communications, August 2006^
- Insights into the effects of diclofenac and other non-steroidal anti-inflammatory agents on ion channels The Journal of Pharmacy and Pharmacology, October 2012^
- Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors The Journal of Neuroscience, October 2001^
- Pharmacological evidence for the activation of K(+) channels by diclofenac European Journal of Pharmacology, March 2002^
- Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis European Journal of Clinical Pharmacology, 1983^
- Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology Drugs, May 2015^
- Selective modification of diclofenac to reduce the adverse effects; A computer-aided drug design approach Informatics in Medicine Unlocked, January 2023^
- Analogue-based drug discovery Wiley-VCH, 2006^
- Process for the production of new substituted phenylacetic acids^
- Diclofenac Drugs.com, retrieved 22 December 2018^
- A breakdown of the over-the-counter medicines market in Britain in 2016 The Pharmaceutical Journal, 28 April 2017, retrieved 23 April 2023^
- Oral diclofenac presentations with legal status 'P' – reclassified to POM www.gov.uk, retrieved 31 March 2015^
- The veterinary use of diclofenac and vulture conservation in Spain: Updated evidence and socio-ecological implications The Science of the Total Environment, Nov 2021^
- South Asian vultures and diclofenac Cambridge Core Blog, 28 September 2022^
- Born to be wild: India's first captive-bred endangered vultures set free The Guardian, 19 August 2021^
- Removing the threat of diclofenac to critically endangered Asian vultures PLOS Biology, Mar 2006^
- Percentage of faecal excretion of meloxicam in the Cape vultures (Gyps corprotheres) Comparative Biochemistry and Physiology. Toxicology & Pharmacology, January 2019^
- Diclofenac residues as the cause of vulture population decline in Pakistan Nature, February 2004^
- 'Decline in vulture population has given rise to diseases': Dr. Vibhu Prakash The Indian Express, 29 August 2016, retrieved 12 December 2018^
- Toxicity of diclofenac to Gyps vultures Biology Letters, 2006^
- Diclofenac toxicity in Gyps vulture is associated with decreased uric acid excretion and not renal portal vasoconstriction Comparative Biochemistry and Physiology. Toxicology & Pharmacology, 2009^
- Vet drug 'killing Asian vultures' BBC News, 28 February 2004, retrieved 25 August 2010^
- Saving the Vultures from Extinction Press Information Bureau, Government of India, 16 May 2005, retrieved 12 May 2006^
- Eagles fall prey to vulture-killing chemical Pune Mirror, 28 May 2014, retrieved 28 May 2014^
- Apparent tolerance of turkey vultures (Cathartes aura) to the non-steroidal anti-inflammatory drug diclofenac Environmental Toxicology and Chemistry, 2008, retrieved 15 July 2019^
- E-010588/2015: answer given by Mr Andriukaitis on behalf of the Commission European Parliament, retrieved 18 February 2024^
- Vulture killing drug now available on EU market International BirdLife, retrieved 18 February 2024^
- First evidence of a vulture killed by veterinary diclofenac in Spain – will the Spanish government and the EU act after this smoking gun? Vulture Conservation Foundation, 7 April 2021, retrieved 8 April 2021^
- Val av smärtstillande påverkar miljön LäkemedelsVärlden, 4 March 2010, retrieved 15 March 2023^
- Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout Aquatic Toxicology, 2004^
- Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss) Aquatic Toxicology, 2004^
- Subletale Wirkungen von Arzneimitteln bei aquatischen Organismen Texte, 2005^
- Ultrastructural effects of pharmaceuticals (carbamazepine, clofibric acid, metoprolol, diclofenac) in rainbow trout (Oncorhynchus mykiss) and common carp (Cyprinus carpio) Analytical and Bioanalytical Chemistry, 2007^
- Itämeren kalat häiriintyvät lääkeaineista – Teollisuudella paineita kehittää eettisempiä pillereitä Yle Uutiset, 10 September 2014, retrieved 15 March 2023^
- Avian scavengers and the threat from veterinary pharmaceuticals Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, November 2014^
- Opinion of the Committee pursuant to Article 30(3) of Regulation (EC) No 726/2004 on the risk to vultures and other necrophagous bird populations in the European Union in connection with the use of veterinary medicinal products containing the substance diclofenac retrieved 16 April 2022^
- Rare European vultures being poisoned by livestock drug The Guardian, 11 April 2021, retrieved 16 April 2022^
- Toxicological effects of diclofenac in four avian species Avian Pathology, 2008^
- Cattle drug threatens thousands of vultures Nature, 2016^